Recently, in vitro models using iPSCs from TSC patients have been derived allowing comparison between the effects attributable to mono- and biallelic loss of TSC1/2 (Costa et al., 2016; Sundberg et al., 2018; Zucco et al., 2018; Winden et al., 2019). The gene discussed is TSC1; the disease is tuberous sclerosis.